No Data
No Data
Stratasys and Siemens Healthineers Bring a New Era for Medical Imaging Research With Patient-Specific 3D-Printed Phantoms
Enhancing Radiology Workflows: Sectra and Siemens Healthineers Enable Seamless Integration Across Systems for Better Patient Care
Siemens Raises $1.5 Billion From Siemens Healthineers Stake Sale
Cubresa and Siemens Healthineers Sign Global Master Interface Agreement for the Cubresa BrainPET Scanner
Siemens Healthineers AG (SEMHF) Q1 2025 Earnings Call Transcript Summary
Siemens Medical shows a strong momentum at the start of the 2025 fiscal year.
Erlangen, Germany, February 7, 2025 /PR Newswire/ -- Recently, Siemens Medical announced its first quarter report for the fiscal year 2025, ending December 31, 2024. The device order shipment ratio for the first quarter of fiscal year 2025 was exceptional, reaching 1.21, with a comparable revenue growth of 5.7%. The imaging Business saw a comparable revenue growth of 7.6%; influenced by special projects, the adjusted EBIT margin reached 18.7%. The laboratory diagnostics business achieved a comparable revenue growth of 1.6%, with an adjusted EBIT margin of 7.8%. The Varian business recorded a comparable revenue growth of 6.2%, with an adjusted EBIT.